世界の結核治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04903)
◆英語タイトル:Global Tuberculosis Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04903
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは結核治療の世界市場について調査・分析した資料です。種類別(活動性結核、潜在性結核)の市場規模、用途別(病院、クリニック)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別結核治療の競争状況、市場シェア
・世界の結核治療市場:種類別市場規模 2015年-2020年(活動性結核、潜在性結核)
・世界の結核治療市場:種類別市場規模予測 2021年-2026年(活動性結核、潜在性結核)
・世界の結核治療市場:用途別市場規模 2015年-2020年(病院、クリニック)
・世界の結核治療市場:用途別市場規模予測 2021年-2026年(病院、クリニック)
・北米の結核治療市場分析:米国、カナダ
・ヨーロッパの結核治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの結核治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の結核治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの結核治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Sanofi、Bayer、Eli Lilly、Labatec Pharma、Macleods Pharmaceuticals、Mylan、Novatis、Otsuka、Patheon、Pfizer
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Tuberculosis Treatment Market
The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Tuberculosis Treatment Scope and Market Size
Tuberculosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi
Bayer
Eli Lilly
Labatec Pharma
Macleods Pharmaceuticals
Mylan
Novatis
Otsuka
Patheon
Pfizer

Market segment by Type, the product can be split into
Active TB
Latent TB
Market segment by Application, split into
Hospital
Clinic

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tuberculosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Active TB
1.4.3 Latent TB
1.5 Market by Application
1.5.1 Global Tuberculosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Tuberculosis Treatment Market Perspective (2015-2026)
2.2 Global Tuberculosis Treatment Growth Trends by Regions
2.2.1 Tuberculosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tuberculosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tuberculosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tuberculosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Tuberculosis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Treatment Players by Market Size
3.1.1 Global Top Tuberculosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Tuberculosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Tuberculosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tuberculosis Treatment Market Concentration Ratio
3.2.1 Global Tuberculosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Treatment Revenue in 2019
3.3 Tuberculosis Treatment Key Players Head office and Area Served
3.4 Key Players Tuberculosis Treatment Product Solution and Service
3.5 Date of Enter into Tuberculosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tuberculosis Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Treatment Market Size by Application (2015-2020)
5.2 Global Tuberculosis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Tuberculosis Treatment Market Size (2015-2020)
6.2 Tuberculosis Treatment Key Players in North America (2019-2020)
6.3 North America Tuberculosis Treatment Market Size by Type (2015-2020)
6.4 North America Tuberculosis Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Tuberculosis Treatment Market Size (2015-2020)
7.2 Tuberculosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Tuberculosis Treatment Market Size by Type (2015-2020)
7.4 Europe Tuberculosis Treatment Market Size by Application (2015-2020)

8 China
8.1 China Tuberculosis Treatment Market Size (2015-2020)
8.2 Tuberculosis Treatment Key Players in China (2019-2020)
8.3 China Tuberculosis Treatment Market Size by Type (2015-2020)
8.4 China Tuberculosis Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Tuberculosis Treatment Market Size (2015-2020)
9.2 Tuberculosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Tuberculosis Treatment Market Size by Type (2015-2020)
9.4 Japan Tuberculosis Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Tuberculosis Treatment Market Size (2015-2020)
10.2 Tuberculosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tuberculosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tuberculosis Treatment Market Size by Application (2015-2020)

11 India
11.1 India Tuberculosis Treatment Market Size (2015-2020)
11.2 Tuberculosis Treatment Key Players in India (2019-2020)
11.3 India Tuberculosis Treatment Market Size by Type (2015-2020)
11.4 India Tuberculosis Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Tuberculosis Treatment Market Size (2015-2020)
12.2 Tuberculosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tuberculosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tuberculosis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Tuberculosis Treatment Introduction
13.1.4 Sanofi Revenue in Tuberculosis Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Tuberculosis Treatment Introduction
13.2.4 Bayer Revenue in Tuberculosis Treatment Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Tuberculosis Treatment Introduction
13.3.4 Eli Lilly Revenue in Tuberculosis Treatment Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Labatec Pharma
13.4.1 Labatec Pharma Company Details
13.4.2 Labatec Pharma Business Overview
13.4.3 Labatec Pharma Tuberculosis Treatment Introduction
13.4.4 Labatec Pharma Revenue in Tuberculosis Treatment Business (2015-2020)
13.4.5 Labatec Pharma Recent Development
13.5 Macleods Pharmaceuticals
13.5.1 Macleods Pharmaceuticals Company Details
13.5.2 Macleods Pharmaceuticals Business Overview
13.5.3 Macleods Pharmaceuticals Tuberculosis Treatment Introduction
13.5.4 Macleods Pharmaceuticals Revenue in Tuberculosis Treatment Business (2015-2020)
13.5.5 Macleods Pharmaceuticals Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview
13.6.3 Mylan Tuberculosis Treatment Introduction
13.6.4 Mylan Revenue in Tuberculosis Treatment Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Novatis
13.7.1 Novatis Company Details
13.7.2 Novatis Business Overview
13.7.3 Novatis Tuberculosis Treatment Introduction
13.7.4 Novatis Revenue in Tuberculosis Treatment Business (2015-2020)
13.7.5 Novatis Recent Development
13.8 Otsuka
13.8.1 Otsuka Company Details
13.8.2 Otsuka Business Overview
13.8.3 Otsuka Tuberculosis Treatment Introduction
13.8.4 Otsuka Revenue in Tuberculosis Treatment Business (2015-2020)
13.8.5 Otsuka Recent Development
13.9 Patheon
13.9.1 Patheon Company Details
13.9.2 Patheon Business Overview
13.9.3 Patheon Tuberculosis Treatment Introduction
13.9.4 Patheon Revenue in Tuberculosis Treatment Business (2015-2020)
13.9.5 Patheon Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Tuberculosis Treatment Introduction
13.10.4 Pfizer Revenue in Tuberculosis Treatment Business (2015-2020)
13.10.5 Pfizer Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Sanofi、Bayer、Eli Lilly、Labatec Pharma、Macleods Pharmaceuticals、Mylan、Novatis、Otsuka、Patheon、Pfizer

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の結核治療市場2026:インサイト・予測(Global Tuberculosis Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。